Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human PAK1 Anticorps:
anti-Mouse (Murine) PAK1 Anticorps:
anti-Rat (Rattus) PAK1 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal PAK1 Primary Antibody pour WB - ABIN1944750
Brown, Stowers, Baer, Trejo, Coughlin, Chant: Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. dans Current biology : CB 1997
Show all 3 Pubmed References
Human PAK1 Primary Antibody pour IHC - ABIN966796
Alexander, Yang, Hinds: Cellular senescence requires CDK5 repression of Rac1 activity. dans Molecular and cellular biology 2004
Show all 3 Pubmed References
Human Polyclonal PAK1 Primary Antibody pour IHC - ABIN966797
Thiel, Reeder, Pfaff, Coleman, Sells, Chernoff: Cell cycle-regulated phosphorylation of p21-activated kinase 1. dans Current biology : CB 2002
Show all 3 Pubmed References
Human Polyclonal PAK1 Primary Antibody pour DB, IF - ABIN389799
El-Baba, Mahadevan, Fahlbusch, S, Rau, Gali-Muhtasib, Schneider-Stock: Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer. dans Molecular cancer 2014
Human Monoclonal PAK1 Primary Antibody pour IF, IHC (p) - ABIN562102
Cook, Sanchez-Carbente, Lachance, Radzioch, Tremblay, Khandjian, DesGroseillers, Murai: Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus. dans PLoS ONE 2011
Human Polyclonal PAK1 Primary Antibody pour ICC, IF - ABIN4343458
Geiger, Velic, Macek, Lundberg, Kampf, Nagaraj, Uhlen, Cox, Mann: Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse. dans Molecular & cellular proteomics : MCP 2013
Human Polyclonal PAK1 Primary Antibody pour IF, IHC - ABIN362773
Rashid, Banerjee, Nikolic: Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. dans The Journal of biological chemistry 2001
Show all 4 Pubmed References
Human Polyclonal PAK1 Primary Antibody pour ELISA, WB - ABIN188561
Zhao, Ma, Calon, Harris-White, Yang, Lim, Morihara, Ubeda, Ambegaokar, Hansen, Weisbart, Teter, Frautschy, Cole: Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. dans Nature neuroscience 2006
results represent the first evidence that Pak1 links extracellular signals to the genetic cascade of transcription factors necessary for cranial neural crest specification
These findings expand the role of phosphoinositides in kinase signaling and suggest how altered phosphoinositide metabolism may upregulate Pak1 activity in cancer cells.
The data suggest that EphA4 activation sequesters active Cdc42 (Montrer CDC42 Anticorps) and in this way down-regulates cell-cell adhesion.
Pak1 inhibition interferes with the guidance of mesendoderm migration by directional cues residing in the extracellular matrix of the blastocoel roof, and with mesendoderm translocation in the embryo.
the oxidative stress-induced (Montrer SQSTM1 Anticorps) down-regulation of PAK1 activity could be involved in the loss of mesencephalic dopaminergic neurons.
the expression of PAK1 is inversely correlated with the level of miR (Montrer MLXIP Anticorps)-494 in human breast cancer samples. Furthermore, re-expression of PAK1 partially reverses miR (Montrer MLXIP Anticorps)-494-mediated proliferative and clonogenic inhibition as well as migration and invasion suppression in breast cancer cells
Our study revealed that PAK1 may play a crucial role in the progression of OSCC. Studying the role of PAK1 and its substrates is likely to enhance our understanding of oral carcinogenesis and potential therapeutic value of PAKs in oral cancer.
The effect of PAK1 modulation on tumorigenesis, and on resistance to treatment with 5-fluorouracil (5-FU), was measured by sphere formation in vitro and by growth of xenografted tumors in vivo. The results show that PAK1 activity correlated with the expression of CSC markers and the CD44 (Montrer CD44 Anticorps) isoform profile, and with tumor growth both in vitro and in vivo.
this study shows that PAK1 may be a potential tumor marker and therapeutic target of prostate cancer
Our results from clinical samples also suggest that Threonine 209 phosphorylation by Pak1 could be a potential therapeutic target and of great clinical relevance with implications for Runx3 (Montrer RUNX3 Anticorps) inactivation in cancer cells where Runx3 (Montrer RUNX3 Anticorps) is known to be oncogenic. The findings presented in this study provide evidence of Runx3 (Montrer RUNX3 Anticorps)-Threonine 209 phosphorylation as a molecular switch in dictating the tissue-specific dualistic functions
Abnormalities in the PAK1 and PAK3 mRNA levels as well as their altered coexpression patterns were observed in the postmortem brain of subjects with depression. Dysregulated PAK1/PAK3 dependent signaling may be a key factor responsible for volumetric abnormalities observed in the hippocampus and in the prefrontal cortex in depression resulting in altered connectivity of these regions.
Short-term treatment of nascent melanoma tumors with PAK inhibitors that block RhoJ (Montrer RHOJ Anticorps) signaling halts the growth of BRAF (Montrer BRAF Anticorps) mutant melanoma tumors in vivo and induces apoptosis in melanoma cells in vitro via a BAD-dependent mechanism
these data strongly support a critical interplay between prolactin (Montrer PRL Anticorps) and estrogen via PAK1 and suggest that ligand-independent activation of ERalpha (Montrer ESR1 Anticorps) through prolactin (Montrer PRL Anticorps)/PAK1 may impart resistance to anti-estrogen therapies.
Given the central role of p21-Activated kinase 1 (PAK1) in vital signaling pathways, studies suggest that clinical development of PAK1 inhibitors will require careful investigation of their safety and efficacy.
These results establish a novel signaling process whereby PAK1 upregulates COX-2 (Montrer COX2 Anticorps), reduces anandamide levels and restricts tonic endocannabinoids-mediated processes.
The findings suggest that PAK1 deficiency may underlie an increased diabetic susceptibility. Discovery of ways to remediate glycaemic dysregulation via altering PAK1 or its downstream effectors offers promising opportunities for disease intervention.
present work presents the correlation between DSCAM gene overexpression and a dysregulation of the PAK pathway, resulting in altered morphological parameters of neuronal plasticity in the trisomic cell line, namely decreased number and length of processes
These results identify Pak1 and Pak2 (Montrer PAK2 Anticorps) as redundant regulators of myoblast differentiation in vitro and in vivo and as components of the promyogenic Ncad (Montrer CDH2 Anticorps)/Cdo (Montrer CDO1 Anticorps)/Cdc42 (Montrer CDC42 Anticorps) signaling pathway.
PAK-mediated phosphorylation of PKD1 at Ser203 triggers its membrane dissociation and subsequent entry into the nucleus, thereby regulating the phosphorylation of PKD1 nuclear targets, including class IIa histone deacetylases.
These results implicate PAK1 as a regulator of Pancreatic stellate cells activation, proliferation and apoptosis. Targeting stromal PAK1 could increase therapeutic response and survival of patients with pancreatic cancer.
The authors conclude that PAK1, besides its role in virus entry, also plays a relevant role in vaccinia virus dissemination.
PAK1 contributes to initiation of intestinal carcinogenesis
Pak1 is essential for adaptive physiological exercise-induced cardiac remodelling and support previous evidence that demonstrates Pak1 signalling is important for cardiac growth and survival.
Further investigations identified Pak1-ERM (Montrer ETV5 Anticorps) as a downstream signaling cascade upon Rac1 activation in the luminal epithelium necessary for uterine receptivity...Rac1 via P38 MAPK (Montrer MAPK14 Anticorps) signaling ensures timely epithelial apoptotic death at postimplantation.
FOXO-Pak1 pathway was recently shown to regulate mammalian neuronal polarity, our findings indicate that the roles of FOXO and Pak1 in neuronal migration are most likely conserved from C. elegans to higher organisms.
PAK1 promotes reproduction, whereas it inactivates HSP16.2 gene and shortens lifespan.
Pak-1 interacts with Wnt (Montrer WNT2 Anticorps) signaling to regulate tissue polarity and gene expression.
only PAK-1 functions in the GIT/PIX (Montrer ARHGEF7 Anticorps)/PAK pathway independently of RAC (Montrer AKT1 Anticorps)/CDC42 (Montrer CDC42 Anticorps) GTPases.
Data show that combined loss of ROCK and PAK, or ROCK and MRCK (Montrer CDC42BPA Anticorps), completely prevented embryonic elongation, but a constitutively active form of MLC-4 could only rescue a lack of MRCK (Montrer CDC42BPA Anticorps).
This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
p21 GTPase-associated kinase 1
, p21-activated kinase 1
, p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast)
, putative CDKN1A-activated kinase 1
, STE20 homolog, yeast
, p21/Cdc42/Rac1-activated kinase 1 (yeast Ste20-related)
, serine/threonine-protein kinase PAK 1
, CDC42/RAC effector kinase PAK-A
, activated protein kinase alpha
, p21 (CDKN1A)-activated kinase 1
, protein kinase MUK2